What is the workup for celiac disease (CeD) using blood tests, specifically serologic testing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for Celiac Disease Blood Testing

The first-line serological test for celiac disease is IgA tissue transglutaminase antibody (tTG-IgA), which must be performed while the patient is consuming gluten for at least 6 weeks prior to testing. 1

Initial Serological Testing Algorithm

  1. Primary Test: IgA tissue transglutaminase antibody (tTG-IgA)

    • Sensitivity: 90-96% in adults, 97.7% in children
    • Specificity: 87.4% in adults, 70.2% in children
    • Threshold: 15-20 U/mL 2, 1
  2. Concurrent Test: Total serum IgA level

    • Must be checked simultaneously with tTG-IgA to rule out IgA deficiency
    • Critical step as IgA deficiency will cause false-negative results on IgA-based tests 1
  3. If IgA Deficient: Order IgG-based testing

    • Options include IgG Deamidated Gliadin Peptide (IgG-DGP) or IgG tissue transglutaminase (IgG-tTG)
    • Note: Isolated positive tTG-IgG with negative tTG-IgA has low utility (3%) in diagnosing celiac disease when not IgA deficient 3

Confirmatory Testing

  1. IgA Endomysial Antibodies (EMA-IgA)

    • Used as a confirmatory test when tTG-IgA is positive
    • Sensitivity: 88% in adults, 94.5% in children
    • Specificity: 99.6% in adults, 93.8% in children
    • Threshold: 1:5 in adults, 1:10 in children
    • Note: EMA testing is more observer-dependent and not available in all laboratories 2, 1
  2. Deamidated Gliadin Peptide Antibodies (DGP)

    • IgA DGP: 96.4% sensitivity in adults
    • IgG DGP: 93.6% sensitivity, 99.4% specificity in adults
    • Useful as additional confirmatory test 2, 1

Important Pre-Testing Requirements

  • Patient must maintain regular gluten consumption for at least 6 weeks prior to testing
  • Recommended gluten intake: 1-3 slices of gluten-containing bread daily
  • Premature gluten restriction can reduce lesion severity and lead to false-negative results 1

HLA Testing Considerations

  • HLA-DQ2/DQ8 testing is not a first-line test but useful in specific scenarios:
    • Patients with Down syndrome
    • Equivocal small-bowel histologic findings
    • Patients already on a gluten-free diet
    • Negative HLA-DQ2/DQ8 virtually excludes celiac disease 1

Common Pitfalls to Avoid

  1. Inadequate gluten consumption: Ensure patient has been consuming adequate gluten (1-3 slices of bread daily) for at least 6 weeks before testing 1

  2. Failure to check total IgA: Always measure total IgA concurrently with tTG-IgA to identify IgA deficiency 1

  3. Relying solely on IgG tTG when IgA is normal: Isolated positive IgG tTG with negative IgA tTG has low diagnostic utility (3%) in non-IgA deficient patients 3

  4. Diagnosing based on dietary response alone: Improvement on gluten restriction is insufficient for diagnosis; proper serological testing is essential 1

  5. Premature gluten restriction: Starting a gluten-free diet before completing testing can lead to false-negative results 1

Remember that positive serological testing should be followed by upper endoscopy with multiple duodenal biopsies (at least 6 specimens from different locations) for definitive diagnosis of celiac disease 1.

References

Guideline

Celiac Disease Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lack of Utility of Anti-tTG IgG to Diagnose Celiac Disease When Anti-tTG IgA Is Negative.

Journal of pediatric gastroenterology and nutrition, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.